Corporate VP Business Development, Novo Nordisk
SVP, Head Global BD & Alliance Management, Merck
VP, Head of Global Neuroscience & Rare Disease Partnering, Ipsen
VP, Scientific Innovation, Oncology, Johnson & Johnson Innovation
SVP Business Development, Oncology & Haematology, Bristol Myers Squibb
Senior Director, Early Innovation Partnering Immunology, EMEA, Johnson & Johnson Innovation
Senior Director, Oncology Worldwide Business Development, GSK
Director, Enterprise Innovation, AbbVie and President-Elect, Women in Bio (WIB)
Assistant General Counsel (Patents), GSK
SVP Talent, Inclusion & Diversity, Bayer
Head of S&E, European BD&L, MSD
Global DEI Director, GSK
Former SVP, Head of Business Development, Amryt Pharma
Head Business Development & Licensing, Debiopharm International
VP, Head of External Innovation, Grünenthal
VP, Global Business Development & Alliances, Orion Pharma
Head of S&E, Novo Nordisk
Vice President Global Head of Business Development, Servier Monde
Director, Corporate Business Development & Strategy, Lundbeck
SVP, Global Head Business Development, GSK
VP, Venture Sciences (Europe Head), Eli Lilly
Senior Director, Search & Evaluation Neuroscience, Eli Lilly and Company
Senior Director, Venture Sciences, Eli Lilly
Corporate Vice President, Global R&D Business Development, Novo Nordisk
Director, Research Beyond Borders, Boehringer Ingelheim
Global Head, BD&L Technologies and Research Beyond Borders, Boehringer Ingelheim
SVP BD, Amgen
VP Head BD & Acquisition, Abbvie
CEO, Vivet Therapeutics
CEO, Calliditas Therapeutics
CEO, Evotec
CEO, CS Medica
CEO, OCON Healthcare
CEO, atai Life Sciences
Head of Business Development, Redx Pharma
CBO, Amphista Therapeutics
CEO, Ziphius Vaccines
CEO, Azafaros
COO, Orion Biotechnology
Head of Business Development, Azafaros
CEO, Insilico Medicine
CEO, Antion Biosciences
CEO, LoQus 23
CEO, Monument Therapeutics
Head of Technology Transfer, Medicines Patent Pool
Technology Office Lead, CEPI
Science Editor, Financial Times
CSO & Co-founder, Ochre Bio and Director, OUTbio
Co-founder and Chief Executive Officer, Apriori Bio & Origination Partner, Flagship Pioneering
Chief Business Officer, BioAge Labs
SVP, Global Market Access & Geographical Expansion, Orchard Therapeutics
CEO, AM-Pharma
CBO, Evotec
Chief Business Officer, Blueprint Medicines
CEO, Bloomsbury Genetic Therapies
CEO, Transine Therapeutics
CEO, Imophoron
Executive Director, Head of External Innovations, Lonza
VP of Licensing, Lonza
Chief Development Officer, COMPASS Pathways
CEO, Cureline
Healthcare Analyst, Trinity Delta
Managing Director, BioPharma Futures
EVP Technical Operations, Achilles Therapeutics
Managing Partner, MediStrava
Editor, Vantage
CEO, Sequana Medical
News Editor, Evaluate Vantage
Global Pharmaceuticals Correspondent, Financial Times
SVP, Global BD, Evotec
Executive Editor, In Vivo
President, Orphalan US
President, Research Manager, Cell and gene Therapy Catapult
Head of Commercial Translation, The Francis Crick Institute
CEO, Apeiron Biologics
CEO, StemMedical
Chief Business Officer, Oxurion
CEO, Roquefort Therapeutics
Chief Corporate Development and Strategy Officer, Alchemb
Managing Partner, Abingworth Life Sciences
Managing Partner, RA Capital Management
Equity Analyst, J.P. Morgan
Lead Manager, AXA Investment Managers
former CEO Ablynx and Chairman to European biotechs
Chief Investment Officer, JP Morgan Life Sciences Private Capital
Partner, Apollo Health Ventures
Managing Partner, Syncona
Partner, Forbion
Partner, Syncona
Partner, Dementia Discovery Fund – SV Health Investors
Principal, Epidarex Capital
Managing Director, M Ventures
Investment Director Life Sciences & HealthTech, Softbank Vision Fund
General Partner, TVM Capital
Partner, INKEF Capital
Principle, Novo Seeds
Principal, High-Tech Gründerfonds
Chief Talent Officer, Oxford Science Enterprises
Managing Director, Raglan Capital
Managing Partner, SV Health Investors
Principal, Monograph Capital
Director, EQT Life Sciences
Managing Director, Awen GmbH
Senior Associate, Jeito
Principal, Sound Bioventures
Principal, Forbion
Co-founder and Partner, Monograph Capital
Venture Advisor, Wellington Partners
Partner, 4BIO Capital
Head of Commercial – Pharmaceuticals, RSSL
Senior Consultant, Halloran Consulting
Head of Health Technologies, Innovate UK
Partner, Brown Rudnick
Principal - Pharmaceuticals & Biotech, Emerging Pharma Lead, ZS Associates
Principal - Portfolio & Pipeline, ZS Associates
Patent Attorney, Fish & Richardson
Vice Chair of the Global Life Sciences Practice, Latham & Watkins
Managing Director & Head of Investment Banking, Back Bay Life Science Advisors
Executive Vice President, Inizio Biotech
Director, Sterne Kessler
Managing Director, Danforth Advisors
Strategic Advisor, NDA Group
Medical Advisor, NDA Group
Partner, Coulter Partners
Head Life Sciences Markets Europe, Middle East & Africa, JLL
Corporate Development , Clarivate
Senior Investment Advisor – Biotech and Pharma, Invest Lithuania
Member, Mintz
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd